Science Explorer Back to mapMap

Most cited papers from CHRISTUS Transplant Institute

What are the most cited papers from CHRISTUS Transplant Institute?

The most cited paper from CHRISTUS Transplant Institute is "Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers" (Ricardo Tomas Spielberger, Patrick J. Stiff, William Bensinger et al., 2004), with 902 citations. Next come "Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's Disease" (715) and "A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus" (672).

Showing 50 of 61 papers. Every paper with more than 69 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers Ricardo Tomas Spielberger, Patrick J. Stiff, William Bensinger et al. · New England Journal of Medicine 15 Dec 2004 902
2 Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's Disease Maria Luisa Escolar, Michele D. Poe, James M. Provenzale et al. · New England Journal of Medicine Open access 18 May 2005 715
3 A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus Damien Chaussabel et al. · Immunity Open access Jul 2008 672
4 First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation Paul J. Martin, J. Douglas Rizzo, John R. Wingard et al. · Transplantation and Cellular Therapy Open access 14 Apr 2012 658
5 Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations Sergio A. Giralt, Luciano J. Costa, Jeffrey R. Schriber et al. · Transplantation and Cellular Therapy Open access 17 Oct 2013 411
6 Ancillary Therapy and Supportive Care of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group Report Daniel R. Couriel et al. · Transplantation and Cellular Therapy Open access 17 Mar 2006 322
7 Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations Thomas A. Gonwa, Linda W. Jennings, Martin L. Mai et al. · Liver Transplantation 31 Jan 2004 314
8 Calcineurin inhibitor‐sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity Stuart M. Flechner, JON A. KOBASHIGAWA, Göran Bo Gustaf Klintmalm · Clinical Transplantation 18 Jun 2007 309
9 Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States Lori S. Muffly et al. · Blood Open access 3 Jul 2017 298
10 Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies Joanne Kurtzberg, Vinod K. Prasad, Shelly L. Carter et al. · Blood Open access 21 Aug 2008 297
11 High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study Richard A. Nash et al. · Blood Open access 24 Apr 2007 265
12 Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results Sham Mailankody, Jeffrey Matous, Saurabh Chhabra et al. · Nature Medicine 23 Jan 2023 258
13 Acute kidney injury following liver transplantation: Definition and outcome Yousri M. Barri, Edmund Q. Sanchez, Linda W. Jennings et al. · Liver Transplantation 27 Apr 2009 247
14 Treatment of Renal Allograft Polyoma BK Virus Infection with Leflunomide Michelle A. Josephson, Daniel L. Gillen, Basit Javaid et al. · Transplantation 9 Mar 2006 227
15 High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis Richard A. Nash et al. · Blood Open access 27 May 2003 222
16 Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation Hien Kim Duong, Bipin N. Savani, Ed Copelan et al. · Transplantation and Cellular Therapy Open access 9 May 2014 216
17 A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease Joanne Kurtzberg, Hisham Abdel‐Azim, Paul A. Carpenter et al. · Transplantation and Cellular Therapy Open access Feb 2020 207
18 Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML Ronan T. Swords, Steven E. Coutre, Michael B. Maris et al. · Blood Open access 18 Jan 2018 205
19 Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Naynesh R. Kamani, Mark C. Walters, Shelly Carter et al. · Transplantation and Cellular Therapy Open access 16 Feb 2012 202
20 Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer Martin S. Tallman, Robert P. Gray, Nicholas J. Robert et al. · New England Journal of Medicine Open access 2 Jul 2003 195
21 Results of the Cord Blood Transplantation Study (COBLT): Outcomes of Unrelated Donor Umbilical Cord Blood Transplantation in Pediatric Patients with Lysosomal and Peroxisomal Storage Diseases Paul Martin, Shelly L. Carter, Nancy A. Kernan et al. · Transplantation and Cellular Therapy Open access 28 Jan 2006 188
22 Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease Paul J. Martin, Barry E. Storer, Scott D. Rowley et al. · Blood Open access 6 Mar 2009 165
23 Allogeneic Transplants in Follicular Lymphoma: Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative Conditioning Parameswaran Hari, Jeanette Carreras, Mei-Jie Zhang et al. · Transplantation and Cellular Therapy Open access 21 Jan 2008 162
24 Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation Kevin Scott Baker et al. · Transplantation and Cellular Therapy Open access 26 Sep 2009 156
25 Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients Stéphan Busque, Joseph R. Leventhal, Daniel C. Brennan et al. · American Journal of Transplantation Open access 18 Jul 2009 154
26 Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis Carla Casulo et al. · Transplantation and Cellular Therapy Open access 11 Dec 2017 143
27 Umbilical cord blood transplantation in adults: Results of the prospective cord blood transplantation (COBLT) Kenneth G. Cornetta, Mary Laughlin, Shelly Carter et al. · Transplantation and Cellular Therapy Open access 29 Jan 2005 143
28 Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium Monica S. Thakar et al. · The Lancet Open access 20 Jun 2023 130
29 The Natural History of Children with Severe Combined Immunodeficiency: Baseline Features of the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium Prospective Study 6901 Christopher C. Dvorak et al. · Journal of Clinical Immunology Open access Jul 2013 130
30 Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors Peter John Shaw et al. · Blood Open access 30 Jul 2010 128
31 Sofosbuvir with peginterferon‐ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis Eric Lawitz, Fred F Poordad, Diana M. Brainard et al. · Hepatology Open access 16 Oct 2014 127
32 Improving Efficacy of Clinical Islet Transplantation with Iodixanol-Based Islet Purification, Thymoglobulin Induction, and Blockage of IL-1β and TNF-α Shinichi Matsumoto, Morihito Takita, Damien Chaussabel et al. · Cell Transplantation Open access Nov 2011 124
33 Preoperative and Perioperative Predictors of the Need for Renal Replacement Therapy After Orthotopic Liver Transplantation Edmund Q. Sanchez, Thomas A. Gonwa, Marlon F. Levy et al. · Transplantation 11 Oct 2004 122
34 Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation Nina Shah et al. · Transplantation and Cellular Therapy Open access 10 Mar 2015 121
35 Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR) HM Lazarus et al. · Bone Marrow Transplantation Feb 2001 117
36 The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Lymphoblastic Leukemia in Adults: An Evidence-based Review Theresa Hahn, Donna Ann Wall, Bruce Matthew Camitta et al. · Transplantation and Cellular Therapy Open access 2006 113
37 Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT David Kyle Buchbinder et al. · Bone Marrow Transplantation Open access 11 Jan 2018 106
38 Early Changes in Kidney Distribution under the New Allocation System Allan B. Massie, Xun Luo, Bonnie E. Lonze et al. · Journal of the American Society of Nephrology Open access 17 Dec 2015 105
39 A Virtual Crossmatch Protocol Significantly Increases Access of Highly Sensitized Patients to Deceased Donor Kidney Transplantation Adam W. Bingaman, Cathi L. Murphey, Juan Palma‐Vargas et al. · Transplantation 15 Dec 2008 105
40 Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia Renata Bizzetto, Carmem Bonfim, Vanderson Rocha et al. · Haematologica Open access 11 Nov 2010 103
41 Effect of Intraoperative Low-dose Dopamine on Renal Function in Liver Transplant Recipients Thomas H. Swygert, L. Clayton Roberts, T. R. Valek et al. · Anesthesiology Open access Oct 1991 99
42 Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy Narendranath Epperla, Ang Li, Brent R. Logan et al. · British Journal of Haematology Open access 2 Mar 2020 96
43 Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases Richard A. Nash, Roger Dansey, Jan Storek et al. · Transplantation and Cellular Therapy Open access Sep 2003 94
44 Hepatorenal Syndrome Richard M. Ruiz, Yousri M. Barri, Linda W. Jennings et al. · Liver Transplantation Open access 30 May 2007 92
45 Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States Fausto Rodriguez Loberiza, Mei‐Jie Zhang, Stephanie J. Lee et al. · Blood Open access 15 Dec 2004 90
46 Long-Term Follow-Up of Patients Who Experienced Graft Failure Postallogeneic Progenitor Cell Transplantation. Results of a Single Institution Analysis Gabriela Rondón, Rima M. Saliba, Issa F. Khouri et al. · Transplantation and Cellular Therapy Open access 19 Jul 2008 89
47 Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor Compared to G-CSF and Cyclophosphamide Paul J. Shaughnessy, Miguel Islas‐Ohlmayer, Julie A. Murphy et al. · Transplantation and Cellular Therapy Open access Sep 2010 88
48 Endpoints for Clinical Trials Testing Treatment of Acute Graft-versus-Host Disease: A Joint Statement Paul J. Martin, Carlos R. Bachier, Hans-Georg Klingemann et al. · Transplantation and Cellular Therapy Open access 14 May 2009 87
49 Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guideline Committee Joseph S. Bubalo, Paul A. Carpenter, Navneet S. Majhail et al. · Transplantation and Cellular Therapy Open access 23 Jan 2014 87
50 Budd–Chiari syndrome: illustrated review of current management John D. Horton, Francisco L. San Miguel, Jorge Ortíz · Liver International 12 Mar 2008 86

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.